The Effects of Cyclooxygenase (COX)-2 Inhibition on Ischemia-Reperfusion Injury in Liver Transplantation

REFERENCES

• O'Leary J G, Lepe R, Davis G L. Indications for liver transplantation. Gastroenterology 2008; 134: 1764–1776
   PubMedGoogle Scholar
• Koffron A, Stein J A. Liver transplantation: indications, pretransplant evaluation, surgery, and posttransplant complications. Med Clin N Am. 2008; 92: 861–888
   PubMedGoogle Scholar
• Duffy J P, Farmer D G, Busuttil R W. A quarter century of liver transplantation at UCLA. Clin Transpl. 2007; 165–170
   PubMedGoogle Scholar
• Fondevila C, Busuttil R W, Kupiec-Weglinski J W. Hepatic ischemia/reperfusion injury: a fresh look. Exp Mol Pathol. 2003; 74: 86–93
   PubMed Web of Science ®Google Scholar
• Howard T K, Klintmalm G B, Cofer J B, et al. The influence of preservation injury on rejection in the hepatic tranplant recipient. Transplantation 1990; 49: 103–107
   PubMed Web of Science ®Google Scholar
• Casillas-Ramirez A, Mosbah I B, Ramalho F, et al. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sciences 2006; 79: 1881–1894
   PubMed Web of Science ®Google Scholar
• Busuttil R W, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transplant. 2003; 9: 651–663
   PubMed Web of Science ®Google Scholar
• Smith W L. Prostanoid biosynthesis and mechanisms of action. Am J Physiol. 1992; 263: F181–F191, (2 pt 2)
   PubMed Web of Science ®Google Scholar
• Mitchell J A, Larkin S, Williams T J. Cyclooxygenase-2: regulation and relevance in inflammation. Biochem Pharmacol. 1995; 50: 1535–1542
   PubMed Web of Science ®Google Scholar
• Oshima K, Takeyoshi I, Tsutsumi H, et al. Inhibition of cyclooxygenase-2 improves cardiac function following long-term preservation. J Surg Res. 2006; 135: 380–384
   PubMedGoogle Scholar
• Sunose Y, Takeyoshi I, Ohwada S, et al. The effect of cyclooxygenase-2 inhibitor FK3311 on ischemia-reperfusion injury in a canine total hepatic vascular exclusion model. J Am Coll Surg. 2001; 192: 54–62
   PubMedGoogle Scholar
• Sunose Y, Takeyoshi I, Tsutsumi H, et al. Effects of FK3311 on pulmonary ischemia-reperfusion injury in a canine model. J Surg Res. 2001; 95: 167–173
   PubMedGoogle Scholar
• Nakamura K, Tsuji K, Konishi N, et al. Studies on anti-inflammatory agents. III. Synthesis and pharmacological properties of metabolites of 4″ acetyl-2″ (2,4-difluorophenoxy) methanesulfonanilide (FK3311). Chem Pharm Bull. 1993; 41: 2050–2052
   PubMed Web of Science ®Google Scholar
• Kamada N, Calne R Y. Orthotopic liver transplantation in the rat: technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28: 47–50
   PubMed Web of Science ®Google Scholar
• Littner M R, Kazmi G M, Lott F D. Distribution of cyclooxygenase products with cyclooxygenase inhibition in isolated dog lung. J Appl Physiol. 1986; 61: 988–993
   PubMed Web of Science ®Google Scholar
• Grossman C J, Wiseman J, Lucas F S, et al. Inhibition of constrictive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and Cox 2 inhibitors. Inflamm Res. 1995; 44: 253–257
   PubMedGoogle Scholar
• Naraba H, Murakami M, Matsumoto H, et al. Segregated coupling of phospholipases A2, cyclooxygenase and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages. J Immunol. 1998; 160: 2974–2982
   PubMed Web of Science ®Google Scholar
• Zamora C A, Baron D A, Heffner J E. Thromboxane contributes to pulmonary hypertension in ischemia-reperfusion lung injury. J Appl Physiol. 1993; 74: 224–229
   PubMed Web of Science ®Google Scholar
• Tsuji K, Nakamura K, Konishi N, et al. Studies on anti-inflammatory agents. IV. Synthesis and Pharmacological properties of 1,5-diarylpyrazoles and related derivatives. Chem Pharm Bull. 1997; 45: 987–995
   PubMed Web of Science ®Google Scholar
• Tsuji K, Nakamura K, Konishi N, et al. Studies on anti-inflammatory agents. I. Synthesis and pharmacological properties of 2″ phenoxy-methanesulfonanilide derivatives. Chem Pharm Bull. 1992; 40: 2399–2409
   PubMedGoogle Scholar
• Kawata K, Takeyoshi I, Iwanami K, et al. The effects of a selective cyclooxygenase-2 inhibitor on small bowel ischemia-reperfusion injury. Hepatogastroenterology 2003; 50: 1970–1974
   PubMedGoogle Scholar
• Ohtani Y, Takeyoshi I, Yoshinari D, et al. Effects of the COX-2 inhibitor FK3311 on ischemia-reperfusion injury in the rat lung. J Invest Surg. 2007; 20: 175–180
   PubMedGoogle Scholar
• Takeyoshi I, Sunose Y, Iwazaki S, et al. The effect of a selective cyclooxygenase-2 inhibitor in extended liver resection with ischemia in dogs. J Surg Res. 2001; 100: 25–31
   PubMed Web of Science ®Google Scholar
• Simon L S. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med. 1999; 106: 37S–42S
   PubMedGoogle Scholar
• Harada N, Okajima K, Kushimoto S, et al. Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic concentration of prostacyclin. Blood 1999; 93: 157–164
   PubMed Web of Science ®Google Scholar
• Naka Y, Roy D K, Liao H, et al. cAMP-mediated vascular protection in an orthotopic rat lung transplant model. Insights into the mechanism of action of prostaglandin E1 to improve lung preservation. Circ Res. 1996; 79: 773–783
   PubMed Web of Science ®Google Scholar
• Shinmura K, Tang X L, Wang Y, et al. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA 2000; 97: 10197–10202
   PubMed Web of Science ®Google Scholar
• Bolli R, Shinmura K, Tang X L, et al. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc Res. 2002; 55: 506–519
   PubMed Web of Science ®Google Scholar
• Camitta M GW, Gabel S A, Chulada P, et al. Cyclooxygenase-1 and –2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning. Circulation 2001; 104: 2453–2458
   PubMed Web of Science ®Google Scholar